Primary |
Product Used For Unknown Indication |
25.0% |
Flatulence |
16.7% |
Abdominal Pain |
8.3% |
Blood Cholesterol Abnormal |
8.3% |
Contraception |
8.3% |
Diarrhoea |
8.3% |
Hypersensitivity |
8.3% |
Hypertension |
8.3% |
Tremor |
8.3% |
|
Abnormal Behaviour |
14.3% |
Death |
14.3% |
Insomnia |
14.3% |
Retinopathy |
14.3% |
Toxicity To Various Agents |
14.3% |
Unintended Pregnancy |
14.3% |
Weight Decreased |
14.3% |
|
Secondary |
Flatulence |
26.1% |
Gastrooesophageal Reflux Disease |
13.0% |
Spinal Fracture |
8.7% |
Blood Cholesterol Abnormal |
4.3% |
Chest Pain |
4.3% |
Contraception |
4.3% |
Diarrhoea |
4.3% |
Drug Use For Unknown Indication |
4.3% |
Dyspnoea |
4.3% |
Genital Herpes |
4.3% |
Hypersensitivity |
4.3% |
Hypertension |
4.3% |
Nausea |
4.3% |
Osteoporosis |
4.3% |
Vomiting |
4.3% |
|
Death |
20.0% |
Restless Legs Syndrome |
13.3% |
Chest Pain |
6.7% |
Drug Prescribing Error |
6.7% |
Flatulence |
6.7% |
Intestinal Obstruction |
6.7% |
Unintended Pregnancy |
6.7% |
Vertigo |
6.7% |
Visual Disturbance |
6.7% |
Vomiting |
6.7% |
Weight Decreased |
6.7% |
Wrong Drug Administered |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
44.6% |
Drug Use For Unknown Indication |
25.9% |
Pain |
4.7% |
Hypertension |
3.0% |
Constipation |
2.9% |
Nausea |
2.5% |
Gastrooesophageal Reflux Disease |
1.8% |
Flatulence |
1.7% |
Prophylaxis |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.2% |
Medical Diet |
1.2% |
Multiple Myeloma |
1.2% |
Anxiety |
1.0% |
Crohn's Disease |
1.0% |
Chemotherapy |
1.0% |
Depression |
1.0% |
Diabetes Mellitus |
1.0% |
Insomnia |
0.9% |
Nuclear Magnetic Resonance Imaging |
0.9% |
Hepatic Neoplasm Malignant |
0.8% |
|
Vomiting |
13.7% |
Death |
8.1% |
Weight Increased |
7.7% |
White Blood Cell Count Decreased |
7.0% |
Weight Decreased |
6.7% |
Renal Failure Acute |
6.3% |
Pyrexia |
6.0% |
Nausea |
4.6% |
Syncope |
4.6% |
Urinary Tract Infection |
4.6% |
Sepsis |
3.9% |
Tremor |
3.9% |
Small Intestinal Obstruction |
3.2% |
Thrombosis |
3.2% |
Wrist Fracture |
3.2% |
Duodenal Ulcer |
2.8% |
Electrocardiogram Qt Prolonged |
2.8% |
Rectal Haemorrhage |
2.8% |
Therapeutic Agent Toxicity |
2.8% |
Pneumonia |
2.5% |
|
Interacting |
Anxiety |
16.7% |
Gastrooesophageal Reflux Disease |
16.7% |
Renal Cancer Metastatic |
16.7% |
Diabetes Mellitus |
8.3% |
Hypertension |
8.3% |
Lung Carcinoma Cell Type Unspecified Stage Iv |
8.3% |
Nausea |
8.3% |
Product Used For Unknown Indication |
8.3% |
Rash |
8.3% |
|
Oesophageal Pain |
66.7% |
Tooth Deposit |
33.3% |
|